Explore the words cloud of the MammoWave project. It provides you a very rough idea of what is the project "MammoWave" about.
The following table provides information about the project.
UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA
|EC max contribution
|50˙000 € (70%)
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
|from 2017-08-01 to 2017-11-30
Take a look of project's partnership.
|UMBRIA BIOENGINEERING TECNOLOGIES SOCIETA A RESPONSABILITA LIMITATA
|IT (FRAZIONE RIVOTORTO)
Breast cancer is the most common cancer in females. Regular screening is of paramount important for early diagnosis to reduce the incidence and increase the outcome of a cure. Current techniques based on ionizing radiation cannot be used in many cases. MammoWave is a mammography device based on safe microwave that enable a fast and accurate breast imaging allowing for an early detection of breast cancer, based on simple technology and low cost. MammoWave can be used any time, at any age and in any condition (pregnancy, specific illness etc.) for all patients since it does not use ionizing radiation. Defer to traditional mammography only cases positive for a first screening MammoWave, limiting the use of harmful radiation. The breast scanner consist of a cup that hold the breast of the patient in a prone position and of two antennas, one to transmit the microwave signal and one to receive. The breast is exposed to completely safe wave field. Both antennas are configured to be moved around the azimuth, to capture reflected electromagnetic field in all directions and measured by the receiving antenna. MammoWave is based on an innovative image reconstruction algorithm that processes the microwave signals according to the Huygens' principle: the result is able to identify the presence of any suspected tumor in the breast tissue. MammoWave addresses the market of hospitals, clinics and private doctors replying to their need of enhancing the specificity of mammography screening in breast cancer detection to battle the increasing rate of false-positive and false-negative results, which implies additional cost for the healthcare system and unnecessary distress for women. The Phase 1 project will be focused on establishing a complete supply chain, a sound business model and commercialization strategy, a planning of all activities for performing the clinical trials in hospital departments, as well as the elaboration of an industrialization and marketing plan
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAMMOWAVE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MAMMOWAVE" are provided by the European Opendata Portal: CORDIS opendata.
PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.Read More
SOFT, the first camera-based colorectal cancer screening test to detect occult blood in faeces immediately and with no lab analysis.Read More
Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphoneRead More